These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36140169)

  • 1. Beneficial Effects of Empagliflozin Are Mediated by Reduced Renal Inflammation and Oxidative Stress in Spontaneously Hypertensive Rats Expressing Human C-Reactive Protein.
    Malínská H; Hüttl M; Marková I; Miklánková D; Hojná S; Papoušek F; Šilhavý J; Mlejnek P; Zicha J; Hrdlička J; Pravenec M; Vaněčková I
    Biomedicines; 2022 Aug; 10(9):. PubMed ID: 36140169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatoprotective and cardioprotective effects of empagliflozin in spontaneously hypertensive rats fed a high-fat diet.
    Hojná S; Malínská H; Hüttl M; Vaňourková Z; Marková I; Miklánková D; Hrdlička J; Papoušek F; Neckář J; Kujal P; Behuliak M; Rauchová H; Kadlecová M; Sedmera D; Neffeová K; Zábrodská E; Olejníčková V; Zicha J; Vaněčková I
    Biomed Pharmacother; 2024 May; 174():116520. PubMed ID: 38581924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive and metabolic effects of empagliflozin in Ren-2 transgenic rats, an experimental non-diabetic model of hypertension.
    Hojná S; Rauchová H; Malínská H; Marková I; Hüttl M; Papoušek F; Behuliak M; Miklánková D; Vaňourková Z; Neckář J; Kadlecová M; Kujal P; Zicha J; Vaněčková I
    Biomed Pharmacother; 2021 Dec; 144():112246. PubMed ID: 34601191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Metformin on Tissue Oxidative and Dicarbonyl Stress in Transgenic Spontaneously Hypertensive Rats Expressing Human C-Reactive Protein.
    Malínská H; Oliyarnyk O; Škop V; Šilhavý J; Landa V; Zídek V; Mlejnek P; Šimáková M; Strnad H; Kazdová L; Pravenec M
    PLoS One; 2016; 11(3):e0150924. PubMed ID: 26963617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex Positive Effects of SGLT-2 Inhibitor Empagliflozin in the Liver, Kidney and Adipose Tissue of Hereditary Hypertriglyceridemic Rats: Possible Contribution of Attenuation of Cell Senescence and Oxidative Stress.
    Trnovska J; Svoboda P; Pelantova H; Kuzma M; Kratochvilova H; Kasperova BJ; Dvorakova I; Rosolova K; Malinska H; Huttl M; Markova I; Oliyarnyk O; Melcova M; Skop V; Mraz M; Stemberkova-Hubackova S; Haluzik M
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salsalate ameliorates metabolic disturbances by reducing inflammation in spontaneously hypertensive rats expressing human C-reactive protein and by activating brown adipose tissue in nontransgenic controls.
    Trnovská J; Šilhavý J; Kuda O; Landa V; Zídek V; Mlejnek P; Šimáková M; Strnad H; Škop V; Oliyarnyk O; Kazdová L; Haluzík M; Pravenec M
    PLoS One; 2017; 12(6):e0179063. PubMed ID: 28586387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosuvastatin ameliorates inflammation, renal fat accumulation, and kidney injury in transgenic spontaneously hypertensive rats expressing human C-reactive protein.
    Šilhavý J; Zídek V; Landa V; Šimáková M; Mlejnek P; Oliyarnyk O; Malínská H; Kazdová L; Mancini M; Pravenec M
    Physiol Res; 2015; 64(3):295-301. PubMed ID: 25536316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sodium-glucose co-transporter 2 inhibitor empagliflozin attenuates cardiac fibrosis and improves ventricular hemodynamics in hypertensive heart failure rats.
    Lee HC; Shiou YL; Jhuo SJ; Chang CY; Liu PL; Jhuang WJ; Dai ZK; Chen WY; Chen YF; Lee AS
    Cardiovasc Diabetol; 2019 Apr; 18(1):45. PubMed ID: 30935417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fumaric acid esters can block pro-inflammatory actions of human CRP and ameliorate metabolic disturbances in transgenic spontaneously hypertensive rats.
    Šilhavý J; Zídek V; Mlejnek P; Landa V; Šimáková M; Strnad H; Oliyarnyk O; Škop V; Kazdová L; Kurtz T; Pravenec M
    PLoS One; 2014; 9(7):e101906. PubMed ID: 25010431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empagliflozin Is Not Renoprotective in Non-Diabetic Rat Models of Chronic Kidney Disease.
    Hojná S; Kotsaridou Z; Vaňourková Z; Rauchová H; Behuliak M; Kujal P; Kadlecová M; Zicha J; Vaněčková I
    Biomedicines; 2022 Oct; 10(10):. PubMed ID: 36289772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In a Prediabetic Model, Empagliflozin Improves Hepatic Lipid Metabolism Independently of Obesity and before Onset of Hyperglycemia.
    Hüttl M; Markova I; Miklankova D; Zapletalova I; Poruba M; Haluzik M; Vaněčkova I; Malinska H
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic cardio- and reno-protective effects of empagliflozin in a prediabetic rat model.
    Huttl M; Markova I; Miklankova D; Oliyarnyk O; Trnovska J; Kucera J; Sedlacek R; Haluzik M; Malinska H
    J Physiol Pharmacol; 2020 Oct; 71(5):. PubMed ID: 33475091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empagliflozin lessened cardiac injury and reduced visceral adipocyte hypertrophy in prediabetic rats with metabolic syndrome.
    Kusaka H; Koibuchi N; Hasegawa Y; Ogawa H; Kim-Mitsuyama S
    Cardiovasc Diabetol; 2016 Nov; 15(1):157. PubMed ID: 27835975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats.
    Chung S; Park CW; Shin SJ; Lim JH; Chung HW; Youn DY; Kim HW; Kim BS; Lee JH; Kim GH; Chang YS
    Nephrol Dial Transplant; 2010 Feb; 25(2):389-99. PubMed ID: 19749146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypolipidemic Effects of Beetroot Juice in SHR-CRP and HHTg Rat Models of Metabolic Syndrome: Analysis of Hepatic Proteome.
    Šilhavý J; Mlejnek P; Šimáková M; Malínská H; Marková I; Hüttl M; Miklánková D; Kazdová L; Vrbacký M; Pecinová A; Mráček T; Pravenec M
    Metabolites; 2023 Jan; 13(2):. PubMed ID: 36837811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice.
    Xu L; Nagata N; Nagashimada M; Zhuge F; Ni Y; Chen G; Mayoux E; Kaneko S; Ota T
    EBioMedicine; 2017 Jun; 20():137-149. PubMed ID: 28579299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Empagliflozin reverses obesity and insulin resistance through fat browning and alternative macrophage activation in mice fed a high-fat diet.
    Xu L; Nagata N; Chen G; Nagashimada M; Zhuge F; Ni Y; Sakai Y; Kaneko S; Ota T
    BMJ Open Diabetes Res Care; 2019; 7(1):e000783. PubMed ID: 31749970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SGLT2 inhibition potentiates the cardiovascular, renal, and metabolic effects of sGC stimulation in hypertensive rats with prolonged exposure to high-fat diet.
    Reverte V; Rodriguez F; Oltra L; Moreno JM; Llinás MT; Shea CM; Schwartzkopf CD; Buys ES; Masferrer JL; Salazar FJ
    Am J Physiol Heart Circ Physiol; 2022 Apr; 322(4):H523-H536. PubMed ID: 35119333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empagliflozin Enhances Autophagy, Mitochondrial Biogenesis, and Antioxidant Defense and Ameliorates Renal Ischemia/Reperfusion in Nondiabetic Rats.
    Ala M; Khoshdel MRF; Dehpour AR
    Oxid Med Cell Longev; 2022; 2022():1197061. PubMed ID: 35126806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empagliflozin, an Inhibitor of Sodium-Glucose Cotransporter 2 Exerts Anti-Inflammatory and Antifibrotic Effects on Experimental Diabetic Nephropathy Partly by Suppressing AGEs-Receptor Axis.
    Ojima A; Matsui T; Nishino Y; Nakamura N; Yamagishi S
    Horm Metab Res; 2015 Aug; 47(9):686-92. PubMed ID: 25611208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.